Stay updated on Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the study details page; the content and structure appear unchanged. Core sections such as Study Overview, Eligibility Criteria, Interventions, and Outcomes remain as in the previous version.
    Difference
    0.4%
    Check dated 2025-11-03T01:21:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Major update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:23:49.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page update adds a new version tag (v3.1.0) and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision tag (v3.0.2), indicating a cleanup of outdated topics rather than adding new core content.
    Difference
    0.4%
    Check dated 2025-09-28T03:20:09.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:38:31.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T15:10:34.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to drug safety and specific medical studies. Notably, the content related to pembrolizumab has been revised, reflecting a shift in focus on drug safety and counterfeit drugs.
    Difference
    4%
    Check dated 2025-08-30T11:52:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.